CLINICAL_TRIALS
trial_result
· 2012-02-03
Clinical Trial Update: BTT-1023 in Rheumatoid Arthritis [Phase 1]
Summary
This document reports that a Phase 1 trial of BTT-1023 for rheumatoid arthritis has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biotie Therapies Corp. | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED